Transfusion Medicine

TRANSFUSION MEDICINE

(BLOOD BANK)

Transfusion Medicine Department of BRB Hospitals Limited is an internationally benchmarked, comprehensive transfusion care facility dedicated to delivering safe, timely, and high-quality transfusion services around the clock. Established in 2014 and operating under a Government-issued license (Blood Bank License No. HSM 7014377; Registration Code: 54411), the department functions in accordance with the principles and requirements of the Safe Blood Transfusion Act, 2002.

Strategically located within the hospital premises, it provides a seamless, 24-hour continuum of transfusion support for patients requiring blood and blood component therapy, therapeutic apheresis, and advanced immunohematology laboratory diagnostics. Driven by a commitment to patient safety, clinical excellence, and technological advancement, the department employs state-of-the-art equipment and modern transfusion technologies, supported by a robust and stringent quality management system.

Every stage—from donor selection and blood collection to component preparation, testing, storage, compatibility assessment, and transfusion support—is governed by rigorous quality and safety standard. BRB Hospitals Limited’s Transfusion Medicine Department strives to ensure a reliable supply of the safest possible blood and blood components, while advancing modern transfusion practices and specialized patient-centered care.

     A. Blood Donor Service: 

·         All donations received in the Transfusion medicine department are voluntary non-remunerated.

·         All necessary safety measures are taken for both the donors and the recipients including performing the mandatory screening tests for infectious diseases (Hepatitis B, Hepatitis C, HIV, Syphilis and Malaria) and hemoglobin estimation.

·         Donor screening is done by well trained staff maintaining donor privacy and confidentiality.

·         Well equipped with automated blood collection monitors for whole blood collection and state of the art – apheresis technology Platelet collection.

      B. Blood Component Services:

·         The department is dedicated to delivering the highest standards of blood and component safety by integrating modern technology, advanced component preparation and storage systems, and robust quality control measures, in line with the latest advancements in modern transfusion medicine.

·         Department is providing 24/7 blood component services.

·         Bedside leukodepletion facilities.

·         Transfusion Medicine Day care services.

·         Available blood component services

a. Whole Blood

b. Red Cell Concentrate

c. Washed Red Cell Concentrate

d. Fresh Frozen Plasma

e. Cryoprecipitate

f.  Cryoprecipitate Poor Plasma

g. Autologous Platelet Rich Plasma

h. Platelet Rich Fibrin

i. Random Donor Platelet

j. Aphaeretic Platelet

k. Reconstituted Blood Component

           C. Serological (Immunohematology) Test Services:

·         Department equipped with fully automated Solid Phase Method (Immucor Echo) and semi-automated Column Agglutination Technology (Orth workstation) analyzer using which will help in solving complex immune-hematological problems which may arise either due to previous pregnancy, transfusion or transplantation as well as autoimmune diseases.

·         Battery of tests:

a.       ABO grouping and Rh D typing

b.      Minor Blood group detection

c.       Coombs’ Test

d.      Rh D antibody detection and titration

e.       Antibody screening and identification

      D. Transfusion Transmitted Infection (TTI) Screening Laboratory:

Fully automated 4th generation Chemiluminscence Assay (Vitros 3600) for mandatory tests i.e. HIV 1&2, p24 antigen, HBsAg and HCV.

      E. Therapeutic Procedures:

a.       Therapeutic Phlebotomy

b.      Therapeutic Plasma Exchange

        The therapeutic use of apheresis technology is done to remove disease causing substances or blood components and providing supportive and therapeutic solutions using state of the art apheresis equipment. We are involved in advances in transfusion medicine.

        F.   Blood Donor Eligibility

1.       The blood donor must be in good physical and mental health.  

2.       Every four month, an individual can donate blood.

3.       In case of Apheretic platelet, blood donor can donate every 15 days.

4.       A blood donor can donate Apheretic platelets one month after donating whole blood.

5.       Age of blood donor should be between 18 to 60 years.

6.       The donor must weigh at least 50 kg or 60 kg in the case of an Apheretic platelet donor.

7.       Body temperature must be below 99.5 degrees Fahrenheit.

8.       Without medication, blood pressure readings: Diastolic 60 to 100 mm Hg, Systolic 100 to 180 mm Hg.  

9.       Minimum Hemoglobin level (12.5 g/100 ml for men, 11.5 g/100 ml for women)

    Platelet counts range from 1,50,000 to 4,50,000/?L (Apheretic Platelet and Platelet Concentrate Donation)

10.   No respiratory illnesses are anticipated.

11.   There will not be any skin conditions

12.   No contagious illnesses (such as Malaria, HIV/AIDS, Syphilis, Hepatitis B, or Hepatitis C) will exist.

13.   There will not be any puncture or scar marks on hand or arms after professional blood donation or medicine injection.

           G.  Permanent Deferral from Blood Donation: Conditions that Preclude Eligibility

Topics 

Topics 

1

Cancer 

11

Rheumatic Fever 

2

Cardiac Disease 

12

Abnormal weight loss 

3

Bleeding Disorder           

13

Insulin controlled diabetes 

4

Liver Disease 

14

Chronic Nephritis 

5

Polycythemia Vera 

15

Endocrine Disorders 

6

Epilepsy 

16

Hepatitis B infection 

7

Tuberculosis 

17

Hepatitis C infection 

8

Asthma  

18

Syphilis Infection 

9

leprosy 

19

HIV/ AIDS 

10

Schizophrenia 

               H. Donor temporarily deferred from donation

1

2

3

4

5

6

Malaria 

7

Undulant fever

8

Skin disease (eczema)

9

Local Infection

Hepatitis B immunization

10

Common Cold/ Flu

11

Tatoo Mark 

Rabies Vaccine

12

Pregnancy

13

Abortion

Immunoglobuline